1 |
Beggs, W.H. 1994. Physicochemical cell damage in relation to lethal amphotericin B action. Antimicrob. Agents Chemother. 38, 363- 364.
DOI
ScienceOn
|
2 |
Blankenship, J.R. and Mitchell, A.P. 2006. How to build a biofilm: a fungal perspective. Curr. Opin. Microbiol. 9, 588-594.
DOI
ScienceOn
|
3 |
Braun, B.R. and Johnson, A.D. 1997. Control of filament formation in Candida albicans by the transcriptional repressor TUP1. Science 277, 105-109.
DOI
|
4 |
Calderone, R.A. and Fonzi, W.A. 2001. Virulence factors of Candida albicans. Trends Microbiol. 9, 327-335.
DOI
ScienceOn
|
5 |
Chandra, J., Kuhn, D.M., Mukherjee, P.K., Hoyer, L.L., McCormick, T., and Ghannoum, M.A. 2001. Biofilm formation by the fungal pathogen Candida albicans: development, architecture, and drug resistance. J. Bacteriol. 183, 5385-5394.
DOI
ScienceOn
|
6 |
Choi E.S., Cho, S.D., Jeon, J.G., and Cho, N.P. 2011. The apoptotic effect of the hexane extract of Rheum undulatum L. in oral cancer cells through the down-regulation of specificity protein 1 and survivin. Lab Anim. Res. 27, 19-24.
DOI
ScienceOn
|
7 |
CLSI. 2008. Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard-third edition; CLSI document M27-A3. Clinical and Laboratory Standards Institute, Wayne, PA, USA.
|
8 |
Cohen, B.E. 1998. Amphotericin B toxicity and lethality: a tale of two channels. Int. J. Pharmaceutics 162, 95-106.
DOI
ScienceOn
|
9 |
Douglas, L.J. 2003. Candida biofilms and their role in infection. Trends Microbiol. 11, 30-36.
DOI
ScienceOn
|
10 |
Edidin, M. 1970. A rapid, quantitative fluorescence assay for cell damage by cytotoxic antibodies. J. Immunol. 104, 1303-1306.
|
11 |
Ehara, M., Noguchi, T., and Ueda, K. 1996. Uptake of neutral red by the vacuoles of a green alga, Micrasterias pinnatifida. Plant Cell Physiol. 37, 734-741.
DOI
|
12 |
Guarrera, P.M. 2005. Traditional phytotherapy in central Italy. Fitotherapia 76, 1-25.
DOI
ScienceOn
|
13 |
Hawser, S. 1996. Adhesion of different Candida spp. to plastic: XTT formazan determinations. Med. Mycol. 34, 407-410.
DOI
|
14 |
Haynes, K. 2001. Virulence in Candida species. Trends Microbiol. 9, 591-596.
DOI
ScienceOn
|
15 |
Krishan, A. 1975. Rapid flow cytofluorometric analysis of mammalian cell cycle by propidium iodide staining. J. Cell Biol. 66, 188-193.
DOI
ScienceOn
|
16 |
Huang, Q., Lu, G., Shen, H.M., Chung, M.C., and Ong, C.N. 2007. Anti-cancer properties of anthraquinones from rhubarb. Med. Res. Rev. 27, 609-630.
DOI
ScienceOn
|
17 |
Kim, Y. 2013. Inhibition of Candida albicans biofilm formation by Coptidis chinensis through damaging the integrity of cell membrane. Kor. J. Microbiol. 49, 17-23.
DOI
|
18 |
Klepser, M.E., Ernst, E.J., Lewis, R.E., Ernst, M.E., and Pfaller, M.A. 1998. Influence of test conditions on antifungal time-kill curve results: proposal for standardized methods. Antimicrob. Agents Chemother. 42, 1207-1212.
|
19 |
Mathur, A., Singh, R., Yousuf, S., Bhardwaj, A., Verma, S.K., Babu, P., Gupta, V., Prasad, G.B.K.S., and Dua, V.K. 2011. Antifungal activity of some plant extracts against clinical pathogens. Adv. Appl. Sci. Res. 2, 260-264.
|
20 |
Odds, F.C., Gow, N.A., and Brown, A.J. 2001. Fungal virulence studies come of age. Genome Biol. 2, reviews 1009.1-1009.4.
|
21 |
Oliver, B.G., Silver, P.M., Marie, C., Hoot, S.J., Leyde, S.E., and White, T.C. 2008. Tetracycline alters drug susceptibility in Candida albicans and other pathogenic fungi. Microbiology 154, 960-970.
DOI
ScienceOn
|
22 |
Park, S.J., Choi, S.J., Shin, W.S., Lee, H.M., Lee, K.S., and Lee, K.H. 2009. Relationship between biofilm formation ability and virulence of Candida albicans. J. Bacteriol. Virol. 39, 119-124.
DOI
|
23 |
Perea, S. and Patterson, T.F. 2002. Antifungal resistance in pathogenic fungi. Clin. Infect. Dis. 35, 1073-1080.
DOI
ScienceOn
|
24 |
Ramage, G., Vande-Walle, K., Wickes, B.L., and Lopez-Ribot, J.L. 2001. Standardized method for in vitro antifungal susceptibility testing of Candida albicans biofilms. Antimicrob. Agents Chemother. 45, 2475-2479.
DOI
ScienceOn
|
25 |
Pfaller, M.A. and Diekema, D.J. 2007. Epidemiology of invasive candidiasis: a persistent public health problem. Clin. Microbiol. Rev. 20, 133-163.
DOI
ScienceOn
|
26 |
Ramage, G., Martinez, J.P., and Lopez-Ribot, J.L. 2006. Candida biofilms on implanted biomaterials: a clinically significant problem. FEMS Yeast Res. 6, 979-986.
DOI
ScienceOn
|
27 |
Ramage, G., Saville, S.P., Thomas, D.P., and Lopez-Ribot, J.L. 2005. Candida biofilms: an update. Eukaryot Cell 4, 633-638.
DOI
ScienceOn
|
28 |
Rukayadi, Y., Shim, J.S., and Hwang, J.K. 2008. Screening of Thai medicinal plants for anticandidal activity. Mycoses 51, 308-312.
DOI
ScienceOn
|
29 |
Shapiro, R.S., Robbins, N., and Cowen, L.E. 2011. Regulatory circuitry governing fungal development, drug resistance, and disease. Microbiol. Mol. Biol. Rev. 75, 213-267.
DOI
|
30 |
Thompson, D.S., Carlisle, P.L., and Kadosh, D. 2011. Coevolution of morphology and virulence in Candida species. Eukaryot. Cell 10, 1173-1182.
DOI
|
31 |
Vaara, M. and Vaara, T. 1981. Outer membrane permeability barrier disruption by polymyxin in polymyxin-susceptible and -resistant Salmonella typhimurium. Antimicrob. Agents Chemother. 19, 578- 583.
DOI
ScienceOn
|
32 |
Viarengo, A., Lowe, D., Bolognesi, C., Fabbri, E., and Koehler, A. 2007. The use of biomarkers in biomonitoring: a 2-tier approach assessing the level of pollutant-induced stress syndrome in sentinel organisms. Comp. Biochem. Physiol. Pt. C. 146, 281-300.
|
33 |
Yu, H.M., Liu, Y.F., Cheng, Y.F., Hu, L.K., and Hou, M. 2008. Effects of rhubarb extract on radiation induced lung toxicity via decreasing transforming growth factor-beta-1 and interleukin-6 in lung cancer patients treated with radiotherapy. Lung Cancer 59, 219-226.
DOI
ScienceOn
|
34 |
White, T.C., Marr, K.A., and Bowden, R.A. 1998. Clinical cellular and molecular factors that contribute to antifungal drug resistance. Clin. Microbiol. Rev. 11, 382-402.
|
35 |
Whiteway, M. and Bachewich, C. 2007. Morphogenesis in Candida albicans. Annu. Rev. Microbiol. 61, 529-553.
DOI
ScienceOn
|